Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Anhui Guangxin Agrochemical Co., Ltd. (603599.SS)
Xuancheng, FJ, CN
Anhui Guangxin Agrochemical Co., Ltd. researches, develops, produces, and sells pesticides technical, preparations, and intermediates in China. It offers fungicides, such as thiophanate-methyl, pyraclostrobin, imazalil, carbendazim, benomyl, and azoxystrobin; herbicides comprising glyphospphate, isoproturon, hexazinone, and diuron; and insecticides, including thiamethoxam, imidacloprid, and chlorpyrifos. The company also provides phosgene intermediates, including o-hydoxybenzonitrile, p-nitrochlorobrnzene, o-nitrochlorobenzene, o-nitroaniline, 2-cyanophenol, phosphorus trichloride, methyl carbamate, o-phenylenediamine, 3,4-dichlorophenyl isocyanate, and ethyl chloroformate; and medicine and new materials consisting of p-nitrophenol sodium salt, p-nitrophenol, and para-aminophenol. It exports its products to Europe, America, Southeast Asia, and internationally. The company was founded in 2000 and is headquartered in Xuancheng, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.90% | -3.12% | -24.65% | -27.99% | -1.15% | -2.53% | +0.99% | -43.31% | -21.75% | +19.55% | +89.02% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-23.9% Q1'26: -7.1% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-16.3% Q1'26: -3.9% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+9.7% ★ Q1'26: +10.1% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+22.4% ★ Q1'26: +21.1% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+6.9% ★ Q1'26: +6.5% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.8% Q1'26: +1.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×2.18× ★ Q1'26: 3.82× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 2 EPS Ana. |
Dec 2027 3 Rev. Ana. 3 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.50B
est: 1.63B (-7.7%)
|
2.35B
est: 2.39B (-1.7%)
|
2.85B
est: 2.65B (+7.3%)
|
3.11B
est: 3.58B (-13.0%)
|
3.40B
est: 3.55B (-4.2%)
|
5.55B
est: 5.61B (-1.1%)
|
9.06B
est: 8.57B (+5.8%)
|
5.87B
est: 4.38B (+33.9%)
|
4.64B
est: 5.41B (-14.1%)
|
3.53B
est: 4.69B (-24.7%)
|
4.97B
4.69B – 5.20B
+5.9% YoY
|
5.56B
4.91B – 6.03B
+12.0% YoY
|
6.47B
6.30B – 6.64B
+16.3% YoY
|
| EBITDA |
294.24M
est: 435.51M (-32.4%)
|
532.09M
est: 638.82M (-16.7%)
|
591.61M
est: 709.94M (-16.7%)
|
635.32M
est: 957.17M (-33.6%)
|
800.29M
est: 950.75M (-15.8%)
|
1.78B
est: 1.50B (+18.6%)
|
2.78B
est: 2.29B (+21.3%)
|
1.56B
est: 1.24B (+26.1%)
|
967.13M
est: 1.53B (-36.8%)
|
1.10B
est: 1.33B (-16.9%)
|
1.41B
1.33B – 1.47B
+5.9% YoY
|
1.57B
1.39B – 1.71B
+12.0% YoY
|
1.83B
1.78B – 1.88B
+16.3% YoY
|
| EBIT |
176.06M
est: 355.08M (-50.4%)
|
391.72M
est: 520.84M (-24.8%)
|
431.07M
est: 578.82M (-25.5%)
|
428.40M
est: 780.39M (-45.1%)
|
571.59M
est: 775.16M (-26.3%)
|
1.56B
est: 1.23B (+27.1%)
|
2.50B
est: 1.87B (+33.7%)
|
1.26B
est: 1.01B (+25.6%)
|
704.26M
est: 1.24B (-43.2%)
|
792.12M
est: 1.08B (-26.4%)
|
1.14B
1.08B – 1.19B
+5.9% YoY
|
1.28B
1.13B – 1.38B
+12.0% YoY
|
1.48B
1.45B – 1.52B
+16.3% YoY
|
| Net Income |
181.13M
est: 563.63M (-67.9%)
|
337.23M
est: 508.20M (-33.6%)
|
469.06M
est: 448.14M (+4.7%)
|
505.65M
est: 526.67M (-4.0%)
|
588.73M
est: 560.56M (+5.0%)
|
1.48B
est: 1.46B (+1.0%)
|
2.32B
est: 2.35B (-1.5%)
|
1.44B
est: 828.23M (+73.7%)
|
778.74M
est: 717.14M (+8.6%)
|
656.91M
est: 728.36M (-9.8%)
|
1.00B
995.03M – 1.01B
+37.8% YoY
|
1.13B
1.07B – 1.18B
+12.7% YoY
|
1.28B
1.11B – 1.36B
+13.3% YoY
|
| SGA |
223.64M
est: 93.59M (+139.0%)
|
179.12M
est: 137.28M (+30.5%)
|
248.88M
est: 152.56M (+63.1%)
|
276.49M
est: 205.69M (+34.4%)
|
223.42M
est: 204.31M (+9.4%)
|
270.33M
est: 322.93M (-16.3%)
|
407.86M
est: 492.69M (-17.2%)
|
346.31M
est: 233.94M (+48.0%)
|
321.32M
est: 288.52M (+11.4%)
|
158.78M
est: 250.35M (-36.6%)
|
265.03M
250.31M – 277.39M
+5.9% YoY
|
296.89M
261.83M – 321.80M
+12.0% YoY
|
345.23M
336.22M – 354.24M
+16.3% YoY
|
| EPS |
0.24
est: 0.62 (-60.7%)
|
0.46
est: 0.56 (-18.0%)
|
0.52
est: 0.49 (+4.1%)
|
0.56
est: 0.58 (-4.5%)
|
0.65
est: 0.62 (+5.0%)
|
1.62
est: 1.62 (+0.2%)
|
2.55
est: 2.60 (-1.7%)
|
1.58
est: 0.91 (+74.0%)
|
0.86
est: 0.86 (+0.0%)
|
0.72
est: 0.81 (-11.1%)
|
1.10
1.09 – 1.11
+35.8% YoY
|
1.23
1.17 – 1.30
+11.8% YoY
|
1.37
1.21 – 1.49
+11.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-28 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-27 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-26 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-25 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-22 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-21 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-20 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-19 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-18 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-15 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-14 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-13 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-12 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-11 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-08 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-07 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-06 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-30 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-29 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 373.4K | 0.06% |
| 2 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 31.8K | 0.26% |
| 3 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 14.1K | 0.48% |
| 4 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 1.57M | 0.06% |
| 5 | Vanguard Total International Stock ETF VXUS | 0.00% | 1.41M | 0.05% |
| 6 | Vanguard ESG International Stock ETF VSGX | 0.00% | 9.3K | 0.10% |
| 7 | Vanguard Total World Stock ETF VT | 0.00% | 107.3K | 0.06% |
| 8 | Vanguard FTSE Global All Cap ex Canada Index ETF VXC.TO | 0.00% | 2.5K | 0.22% |
| 9 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 7.6K | 0.22% |
| 10 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 4.1K | 0.22% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Degang Zhou | Accounting Supervisor | — | — |
| Jin Xiang Huang | GM & Chairman | — | male |
| Wang Zhen He | Chief Financial Officer & Director | — | female |
| Xiaoming Yuan | Deputy GM & Director | — | female |
| Yingjie Zhao | Board Secretary & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 603599.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
